ATP Hydrolysis by α‐Synuclein Amyloids is Mediated by Enclosing β‐Strand
Pathological amyloids, like those formed by α-synuclein in Parkinson's disease, are recently found to catalyze the hydrolysis of model substrates in vitro. Here it is reported that the universal energy molecule ATP is another substrate for α-synuclein amyloid chemical catalysis. To reveal the underlying mechanism, the high-resolution cryo-EM structure of the amyloids in the presence of ATP is solved. The structure reveals a type 1A amyloid fold with an additional β-strand involving residues 16-22 that wraps around the ATP, creating an enclosed cavity at the interface of the protofilaments. Mutations of putative ATP-interacting residues in the cavity and the additional β-strand showed that replacing any one of Lys21, Lys23, Lys43, Lys45, and Lys60 with Ala reduced amyloid-mediated ATPase activity. High-resolution structural analysis of Lys21Ala α-synuclein amyloids in the presence of ATP reveals the same fold as wild-type α-synuclein amyloids but without the extra β-strand and with ATP oriented differently. It is concluded that positively-charged side chains, along with ordering of the N-terminal part into a β-strand, enclosing the cavity, are essential parameters governing ATP hydrolysis by α-synuclein amyloids. Amyloid-catalyzed ATP hydrolysis may hamper ATP-dependent rescue systems near amyloid deposits in vivo.
Authors
- István Horváth (ORCID: https://orcid.org/0000-0003-4262-1430)
- Fiamma A. Buratti (ORCID: https://orcid.org/0000-0001-5749-9883)
- Lukas Frey (ORCID: https://orcid.org/0000-0002-1052-1104)
- Pernilla Wittung‐Stafshede (ORCID: https://orcid.org/0000-0003-1058-1964)
- Shraddha Parate (ORCID: https://orcid.org/0000-0001-6566-7496)
- Roland Riek (ORCID: https://orcid.org/0000-0002-6333-066X)
- Ranjeet Kumar (ORCID: https://orcid.org/0000-0002-5859-7933)
Institutions
- Medical Protective (US)
- ETH Zurich (CH)
- Chalmers University of Technology (SE)
- Rice University (US)
Publication Details
- Journal
- Advanced Science
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1002/advs.202508441
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Swedish Cancer Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet